SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-291199
Filing Date
2020-11-12
Accepted
2020-11-12 10:15:59
Documents
5
Period of Report
2020-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d95662d8k.htm 8-K 24220
2 EX-1.1 d95662dex11.htm EX-1.1 184095
3 EX-4.1 d95662dex41.htm EX-4.1 84816
4 EX-99.1 d95662dex991.htm EX-99.1 14081
5 GRAPHIC g95662g1112112110953.jpg GRAPHIC 5332
  Complete submission text file 0001193125-20-291199.txt   315883
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 201304325
SIC: 2834 Pharmaceutical Preparations